Cargando…

Development and internal validation of a screening tool for chronic prostatitis (S-CP)

PURPOSE: We developed a simple self-checkable screening tool for chronic prostatitis (S-CP) and internally validated it to encourage men (in the general population) with possible chronic prostatitis to consult urologists. METHODS: The expert panel proposed the S-CP, which comprises three domains: Ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Tohi, Yoichiro, Hijikata, Yasukazu, Sugimoto, Mikio, Kuroda, Hideya, Takei, Mineo, Matsuki, Takakazu, Kamitani, Tsukasa, Kakehi, Yoshiyuki, Fukuhara, Shunichi, Yamamoto, Yosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582131/
https://www.ncbi.nlm.nih.gov/pubmed/37712967
http://dx.doi.org/10.1007/s00345-023-04574-x
_version_ 1785122262029959168
author Tohi, Yoichiro
Hijikata, Yasukazu
Sugimoto, Mikio
Kuroda, Hideya
Takei, Mineo
Matsuki, Takakazu
Kamitani, Tsukasa
Kakehi, Yoshiyuki
Fukuhara, Shunichi
Yamamoto, Yosuke
author_facet Tohi, Yoichiro
Hijikata, Yasukazu
Sugimoto, Mikio
Kuroda, Hideya
Takei, Mineo
Matsuki, Takakazu
Kamitani, Tsukasa
Kakehi, Yoshiyuki
Fukuhara, Shunichi
Yamamoto, Yosuke
author_sort Tohi, Yoichiro
collection PubMed
description PURPOSE: We developed a simple self-checkable screening tool for chronic prostatitis (S-CP) and internally validated it to encourage men (in the general population) with possible chronic prostatitis to consult urologists. METHODS: The expert panel proposed the S-CP, which comprises three domains: Area of pain or discomfort (6 components), accompanying Symptom (6 components), and Trigger for symptom flares (4 components). We employed logistic regression to predict chronic prostatitis prevalence with the S-CP. We evaluated the predictive performance using data from a representative national survey of Japanese men aged 20 to 84. We calculated the optimism-adjusted area under the curve using bootstrapping. We assessed sensitivity/specificity, likelihood ratio, and predictive value for each cutoff of the S-CP. RESULTS: Data were collected for 5,010 men—71 (1.4%) had a chronic prostatitis diagnosis. The apparent and adjusted area under the curve for the S-CP was 0.765 [95% confidence interval (CI) 0.702, 0.829] and 0.761 (0.696, 0.819), respectively. When the cutoff was two of the three domains being positive, sensitivity and specificity were 62.0% (95% CI 49.7, 73.2) and 85.4% (95% CI 84.4, 86.4), respectively. The positive/negative likelihood ratios were 4.2 (95% CI 3.5, 5.2) and 0.45 (95% CI 0.33, 0.60), respectively. The positive/negative predictive values were 5.7 (95% CI 4.2, 7.6) and 99.4 (95% CI 99.1, 99.6), respectively. CONCLUSION: The reasonable predictive performance of the S-CP indicated that patients (in the general population) with chronic prostatitis were screened as a first step. Further research would develop another tool for diagnostic support in actual clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00345-023-04574-x.
format Online
Article
Text
id pubmed-10582131
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105821312023-10-19 Development and internal validation of a screening tool for chronic prostatitis (S-CP) Tohi, Yoichiro Hijikata, Yasukazu Sugimoto, Mikio Kuroda, Hideya Takei, Mineo Matsuki, Takakazu Kamitani, Tsukasa Kakehi, Yoshiyuki Fukuhara, Shunichi Yamamoto, Yosuke World J Urol Original Article PURPOSE: We developed a simple self-checkable screening tool for chronic prostatitis (S-CP) and internally validated it to encourage men (in the general population) with possible chronic prostatitis to consult urologists. METHODS: The expert panel proposed the S-CP, which comprises three domains: Area of pain or discomfort (6 components), accompanying Symptom (6 components), and Trigger for symptom flares (4 components). We employed logistic regression to predict chronic prostatitis prevalence with the S-CP. We evaluated the predictive performance using data from a representative national survey of Japanese men aged 20 to 84. We calculated the optimism-adjusted area under the curve using bootstrapping. We assessed sensitivity/specificity, likelihood ratio, and predictive value for each cutoff of the S-CP. RESULTS: Data were collected for 5,010 men—71 (1.4%) had a chronic prostatitis diagnosis. The apparent and adjusted area under the curve for the S-CP was 0.765 [95% confidence interval (CI) 0.702, 0.829] and 0.761 (0.696, 0.819), respectively. When the cutoff was two of the three domains being positive, sensitivity and specificity were 62.0% (95% CI 49.7, 73.2) and 85.4% (95% CI 84.4, 86.4), respectively. The positive/negative likelihood ratios were 4.2 (95% CI 3.5, 5.2) and 0.45 (95% CI 0.33, 0.60), respectively. The positive/negative predictive values were 5.7 (95% CI 4.2, 7.6) and 99.4 (95% CI 99.1, 99.6), respectively. CONCLUSION: The reasonable predictive performance of the S-CP indicated that patients (in the general population) with chronic prostatitis were screened as a first step. Further research would develop another tool for diagnostic support in actual clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00345-023-04574-x. Springer Berlin Heidelberg 2023-09-15 2023 /pmc/articles/PMC10582131/ /pubmed/37712967 http://dx.doi.org/10.1007/s00345-023-04574-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Tohi, Yoichiro
Hijikata, Yasukazu
Sugimoto, Mikio
Kuroda, Hideya
Takei, Mineo
Matsuki, Takakazu
Kamitani, Tsukasa
Kakehi, Yoshiyuki
Fukuhara, Shunichi
Yamamoto, Yosuke
Development and internal validation of a screening tool for chronic prostatitis (S-CP)
title Development and internal validation of a screening tool for chronic prostatitis (S-CP)
title_full Development and internal validation of a screening tool for chronic prostatitis (S-CP)
title_fullStr Development and internal validation of a screening tool for chronic prostatitis (S-CP)
title_full_unstemmed Development and internal validation of a screening tool for chronic prostatitis (S-CP)
title_short Development and internal validation of a screening tool for chronic prostatitis (S-CP)
title_sort development and internal validation of a screening tool for chronic prostatitis (s-cp)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582131/
https://www.ncbi.nlm.nih.gov/pubmed/37712967
http://dx.doi.org/10.1007/s00345-023-04574-x
work_keys_str_mv AT tohiyoichiro developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT hijikatayasukazu developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT sugimotomikio developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT kurodahideya developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT takeimineo developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT matsukitakakazu developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT kamitanitsukasa developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT kakehiyoshiyuki developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT fukuharashunichi developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp
AT yamamotoyosuke developmentandinternalvalidationofascreeningtoolforchronicprostatitisscp